Mutual Advisors »

Immunitybio shares owned by Mutual Advisors

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Mutual Advisors from 13F filings

Historical chart of Mutual Advisors investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Mutual Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Mutual Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $66k 28k 2.39
2025-06-30 $46k 16k 2.86
2025-03-31 $42k 16k 2.61
2024-12-31 $49k 16k 3.04

More positions owned by Mutual Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Ishares Tr Ishs 5-10yr Invt (IGIB)

View all positions for Mutual Advisors

Top funds holding Immunitybio

Vanguard Group
BlackRock
Jane Street
State Street Corporation
Geode Capital Management
Heights Capital Management
Woodline Partners
Susquehanna International
AlphaCore Capital
Morgan Stanley
Two Sigma Investments
Tang Capital Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust

View all funds holding Immunitybio